Cachan, France

Daniel Ladant

USPTO Granted Patents = 14 

 

 

Average Co-Inventor Count = 4.3

ph-index = 6

Forward Citations = 93(Granted Patents)


Company Filing History:


Years Active: 1993-2021

Loading Chart...
Loading Chart...
Loading Chart...
14 patents (USPTO):Explore Patents

Title: Daniel Ladant: Innovator in Protein Detection and Toxin Production

Introduction:

Daniel Ladant, hailing from Cachan, France, is an esteemed inventor and researcher in the fields of protein detection and toxin production. With a strong background in molecular biology and biochemistry, he has made significant contributions to the scientific community with his innovative patents and research. This article will shed light on Ladant's latest patents, career highlights, notable collaborations, and his invaluable contributions to the field of biotechnology.

Latest Patents:

Ladant's most recent patents highlight his expertise in protein detection and the production of functional toxins. In his patent titled "Monomeric and Functional Adenylate Cyclase CyaA Toxin," Ladant presents a groundbreaking procedure for producing a stable, functional form of CyaA toxin, particularly creating monomeric and functional spCyaA toxin without the need for chaotropic agents. This innovation can have far-reaching applications in various fields, including medicine and drug discovery.

Another notable patent by Ladant, titled "In Vivo Detection of Protein Interaction Based on Adenylate Cyclase Hybrid System," focuses on a method to detect protein-ligand interactions using an adenylate cyclase enzyme (AC) and calmodulin (CaM) as interacting partners. This technology, utilizing a low number of chimeric polypeptides with decreased affinity, enables the detection of high-affinity interactions like antigen-antibody interactions. Moreover, it allows for the characterization of toxic moieties, which was previously challenging.

Career Highlights:

Ladant's impressive career encompasses extensive work at renowned institutions. He has notably contributed to the faculty of Institut Pasteur, a leading French research institute renowned for its contributions to medical science. Additionally, Ladant has served as a researcher at the Centre National De La Recherche Scientifique, a prominent institution dedicated to advancing scientific knowledge.

Collaborations:

Throughout his professional journey, Ladant has had the pleasure of collaborating with esteemed colleagues who have enriched his research endeavors. Notably, he has worked alongside Claude Leclerc, a distinguished researcher in the field of immunology, whose expertise has complemented Ladant's research in protein interactions. Agnes Ullmann, another collaborator, has contributed invaluable insights into the fields of molecular biology and biochemistry, aligning with Ladant's research interests.

Conclusion:

Daniel Ladant's outstanding contributions to the scientific community stand as a testament to his expertise in protein detection and toxin production. His innovative patents, including the development of a stable form of CyaA toxin and the detection of protein-ligand interactions using adenylate cyclase, demonstrate his commitment to pushing the boundaries of biotechnology. Collaborating with esteemed partners and working at prestigious institutions such as Institut Pasteur and the Centre National De La Recherche Scientifique, Ladant continues to leave a lasting impact on the field. We can anticipate further groundbreaking inventions and research from this remarkable innovator in the years to come.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…